1. Home
  2. IGC vs HERZ Comparison

IGC vs HERZ Comparison

Compare IGC & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.27

Market Cap

28.5M

Sector

Health Care

ML Signal

HOLD

Logo Herzfeld Credit Income Fund Inc.

HERZ

Herzfeld Credit Income Fund Inc.

HOLD

Current Price

$18.29

Market Cap

30.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGC
HERZ
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
28.5M
30.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IGC
HERZ
Price
$0.27
$18.29
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.13
N/A
AVG Volume (30 Days)
421.1K
N/A
Earning Date
02-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,106,000.00
N/A
Revenue This Year
$3.54
N/A
Revenue Next Year
$15.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
N/A
52 Week High
$0.50
N/A

Technical Indicators

Market Signals
Indicator
IGC
HERZ
Relative Strength Index (RSI) 39.34 94.16
Support Level $0.27 $1.80
Resistance Level $0.30 $19.30
Average True Range (ATR) 0.01 0.37
MACD -0.00 1.97
Stochastic Oscillator 30.29 93.89

Price Performance

Historical Comparison
IGC
HERZ

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About HERZ Herzfeld Credit Income Fund Inc.

Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.

Share on Social Networks: